Vertex Pharmaceuticals IncorporatedVRTX
Price as of · delayed, not real-time
A biotechnology company focused on developing and commercializing therapies for serious diseases, with a primary concentration in cystic fibrosis. Its portfolio of CF treatments generates the majority of revenue, supporting expansion into gene-editing and cell therapies for conditions including sickle cell disease, beta thalassemia, and type 1 diabetes. Investors closely monitor its pipeline diversification, regulatory milestones, and the durability of its cystic fibrosis franchise, which underpins cash flow and long-term growth expectations.
Congressional Interest in Vertex Pharmaceuticals Incorporated (VRTX)
10 members of Congress have disclosed 98 trades in Vertex Pharmaceuticals Incorporated (VRTX), a Healthcare company. The buy/sell breakdown shows 23 purchases versus 27 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading VRTX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-08-26 | David Taylor | sell | $1K-$15K |
| 2026-06-02 | Rohit Khanna | buy | $1K-$15K |
| 2026-05-27 | Rohit Khanna | sell | $1K-$15K |
| 2026-04-24 | Rohit Khanna | buy | $1K-$15K |
| 2026-04-13 | Rohit Khanna | buy | $1K-$15K |
| 2026-03-30 | Rohit Khanna | sell | $1K-$15K |
| 2026-03-27 | Alan Armstrong | buy | $1K-$15K |
| 2026-03-23 | Rohit Khanna | sell | $1K-$15K |
| 2026-02-05 | Rohit Khanna | buy | $1K-$15K |
| 2026-01-29 | David Taylor | sell | $1K-$15K |
| 2026-01-29 | Rohit Khanna | sell | $1K-$15K |
| 2026-01-23 | Rohit Khanna | buy | $1K-$15K |
| 2025-10-13 | MICHAEL T. MCCAUL | buy | $50K-$100K |
| 2025-10-07 | Rohit Khanna | sell | $1K-$15K |
| 2025-09-25 | Rohit Khanna | sell | $1K-$15K |
| 2025-08-07 | David Taylor | buy | $1K-$15K |
| 2025-06-23 | Rohit Khanna | buy | $1K-$15K |
| 2025-06-11 | Lisa McClain | sell | $1K-$15K |
| 2025-06-10 | Lisa McClain | sell | $1K-$15K |
| 2025-05-12 | Jefferson Shreve | sell | $15K-$50K |
| 2025-03-20 | Byron Donalds | sell | $1K-$15K |
| 2025-03-20 | Byron Donalds | sell | $1K-$15K |
| 2025-03-13 | Jefferson Shreve | buy | $15K-$50K |
| 2025-02-25 | Rohit Khanna | buy | $1K-$15K |
| 2025-02-24 | Jefferson Shreve | buy | $15K-$50K |
| 2025-02-19 | Rohit Khanna | sell | $1K-$15K |
| 2025-01-22 | Rohit Khanna | sell | $1K-$15K |
| 2024-12-16 | Rohit Khanna | sell | $1K-$15K |
| 2024-12-16 | Rohit Khanna | buy | $1K-$15K |
| 2024-12-11 | Lisa McClain | buy | $1K-$15K |
| 2024-11-15 | Rohit Khanna | buy | $1K-$15K |
| 2024-10-23 | Julia Letlow | buy | $1K-$15K |
| 2024-10-11 | Rohit Khanna | sell | $1K-$15K |
| 2024-10-04 | Rohit Khanna | buy | $1K-$15K |
| 2024-08-26 | Rohit Khanna | sell | $1K-$15K |
| 2024-08-02 | Rohit Khanna | sell | $50K-$100K |
| 2024-08-02 | Rohit Khanna | sell | $1K-$15K |
| 2023-12-05 | Rohit Khanna | sell | $1K-$15K |
| 2023-10-31 | MICHAEL T. MCCAUL | buy | $1K-$15K |
| 2023-10-24 | Greg Stanton | sell | $1K-$15K |
| 2023-09-26 | Greg Stanton | buy | $1K-$15K |
| 2023-08-11 | Rohit Khanna | buy | $1K-$15K |
| 2023-07-26 | Rohit Khanna | sell | $1K-$15K |
| 2023-06-29 | Rohit Khanna | sell | $1K-$15K |
| 2023-05-23 | Rohit Khanna | sell | $1K-$15K |
| 2023-01-17 | Rohit Khanna | sell | $1K-$15K |
| 2022-12-28 | MICHAEL T. MCCAUL | sell | $15K-$50K |
| 2022-12-07 | Byron Donalds | buy | $1K-$15K |
| 2022-12-07 | Byron Donalds | buy | $1K-$15K |
| 2022-10-06 | Thomas H Tuberville | buy | $1K-$15K |